Logo

Pyrosequencing Completes Biotage Acquisition

Oct 30, 2003

NEW YORK, Oct. 29 (GenomeWeb News) - Pyrosequencing said today it has completed the acquisition of Biotage, which the parties announced Oct. 14.

 

In the acquisition, Pyrosequencing, of Uppsala, Sweden, said it made a cash payment of 235 million SEK ($30.5 million  ) and took over a mortgage of 36 million SEK for Biotage's Virginia premises.

 

The acquisition is the second this year for Pyrosequencing. The company acquired Personal Chemistry in September.

 

The company said it will now have about 275 employees, and also said it will likely change its name to Biotage.

 

 

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.